Cargando…
Retinitis Pigmentosa: Novel Therapeutic Targets and Drug Development
Retinitis pigmentosa (RP) is a heterogeneous group of hereditary diseases characterized by progressive degeneration of retinal photoreceptors leading to progressive visual decline. It is the most common type of inherited retinal dystrophy and has a high burden on both patients and society. This cond...
Autores principales: | Wu, Kevin Y., Kulbay, Merve, Toameh, Dana, Xu, An Qi, Kalevar, Ananda, Tran, Simon D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9963330/ https://www.ncbi.nlm.nih.gov/pubmed/36840007 http://dx.doi.org/10.3390/pharmaceutics15020685 |
Ejemplares similares
-
Retinal Prostheses: Engineering and Clinical Perspectives for Vision Restoration
por: Wu, Kevin Y., et al.
Publicado: (2023) -
Targeting of the NRL Pathway as a Therapeutic Strategy to Treat Retinitis Pigmentosa
por: Moore, Spencer M., et al.
Publicado: (2020) -
PKM2 Is a Potential Diagnostic and Therapeutic Target for Retinitis Pigmentosa
por: Zhu, Peiwen, et al.
Publicado: (2021) -
Retinitis pigmentosa
por: Hamel, Christian
Publicado: (2006) -
Neuroinflammation as a Therapeutic Target in Retinitis Pigmentosa and Quercetin as Its Potential Modulator
por: Ortega, Joseph Thomas, et al.
Publicado: (2021)